014570 — Korean Drug Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩52bn
- KR₩33bn
- KR₩73bn
- 98
- 75
- 19
- 73
Annual cashflow statement for Korean Drug Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7,360 | 9,042 | 11,809 | -4,917 | 2,995 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4,284 | 3,884 | 2,584 | 12,939 | 2,645 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -669 | -5,590 | -9,863 | -11,770 | -2,841 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 12,330 | 8,806 | 5,913 | -1,999 | 4,869 |
| Capital Expenditures | -759 | -1,159 | -6,477 | -5,934 | -1,043 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -9,531 | -7,095 | 1,076 | 18,211 | -9,846 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -10,290 | -8,254 | -5,401 | 12,277 | -10,889 |
| Financing Cash Flow Items | — | — | — | -2.9 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,161 | -2,789 | -1,906 | -2,008 | -1,573 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 797 | -2,227 | -1,415 | 8,263 | -7,586 |